Stock MLYS MINERALYS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Mineralys Therapeutics, Inc.

Equities

MLYS

US6031701013

Market Closed - Nasdaq
Other stock markets
 01:30:00 25/06/2024 am IST 		5-day change 1st Jan Change
12.63 USD +4.90% Intraday chart for Mineralys Therapeutics, Inc. +3.52% +46.86%
20/06 Mineralys Therapeutics Insider Sold Shares Worth $592,022, According to a Recent SEC Filing MT
14/06 Mineralys Therapeutics, Inc. Announces Changes to its Board CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Mineralys Therapeutics Insider Sold Shares Worth $592,022, According to a Recent SEC Filing
MT
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors
AQ
Mineralys Therapeutics, Inc. Announces Changes to its Board
CI
Mineralys Therapeutics Insider Sold Shares Worth $1,252,718, According to a Recent SEC Filing
MT
Transcript : Mineralys Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 04:00 PM
Mineralys Therapeutics : Corporate Overview June 2024
PU
Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
AQ
Transcript : Mineralys Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 05:01 PM
Mineralys Therapeutics : Corporate Overview May 2024
PU
Transcript : Mineralys Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Mineralys Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
AQ
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
AQ
Mineralys Therapeutics, Inc. Announces Alexander Asam Informs That His Decision Not to Stand for Re-Election to the Board
CI
Goldman Sachs Initiates Mineralys Therapeutics at Buy With $30 Price Target
MT
Mineralys Therapeutics Files Mixed-Securities Shelf Registration
MT
Transcript : Mineralys Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Mineralys Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Mineralys Therapeutics : Corporate Overview March 2024
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MLYS Stock
  4. News Mineralys Therapeutics, Inc.